Access抗苗勒管激素检测预测卵巢低反应的验证研究
该前瞻性队列研究在15个生殖中心纳入472例21-45岁拟行控制性卵巢刺激的女性,验证Access AMH检测的0.93 ng/mL切点预测卵巢低反应(≤4个卵母细胞)的效能,ROC曲线下面积0.852,灵敏度63.5%、特异度89.2%,血清与血浆AMH高度相关(r=0.9980)。
要点
- Access AMH检测0.93 ng/mL切点验证有效,ROC曲线下面积0.852。
- 该切点灵敏度63.5%、特异度89.2%,阳性预测值52.2%、阴性预测值92.9%。
- 血清与血浆AMH值高度相关(r=0.9980),切点可能因检测方法而异。
核心结论
- 研究验证了既往建立的AMH切点对卵巢低反应的预测效能。
- AMH切点可能因检测方法不同而变化,文献中应尽可能报告具体的AMH检测方法。
研究设计与样本
- 前瞻性队列研究,在15个私立和学术生育中心(美国14个、加拿大1个)开展。
- 纳入472例21-45岁拟行体外受精控制性卵巢刺激的女性,无干预。
- 主要结局为获卵数,分为卵巢低反应(≤4个卵母细胞)和正常至高等反应。
主要发现
- 卵巢低反应组平均血清AMH为0.99 ng/mL(中位数0.76 ng/mL),正常至高等反应组为2.83 ng/mL(中位数2.36 ng/mL)。
- 验证0.93 ng/mL切点预测卵巢低反应的ROC曲线下面积为0.852,灵敏度63.5%、特异度89.2%。
- 阳性预测值为52.2%,阴性预测值为92.9%。
- 血浆AMH值与血清AMH值高度相关,r值为0.9980。
- 既往建立的AMH切点1.77 ng/mL预测窦卵泡计数>15的灵敏度为83.8%(95%CI 77.7-88.5),特异度为59.9%(95%CI 54.2-65.4)。
关键数值与推荐
- 卵巢低反应定义为获卵数≤4个。
- Access AMH检测的0.93 ng/mL切点用于预测卵巢低反应,血清和血浆均验证。
- AMH切点1.77 ng/mL用于预测窦卵泡计数>15。
临床怎么用
- 可使用Access AMH检测的0.93 ng/mL切点识别卵巢低反应风险高的患者。
- 解读AMH切点时应考虑所用检测方法,并在报告中注明具体检测方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the diagnostic performance of the antimüllerian hormone (AMH) level determined using the Access AMH assay for predicting poor ovarian response (POR) defined as ≤4 oocytes retrieved, including the validation of the predefined AMH cutoff of 0.93 ng/mL in both serum and plasma. DESIGN: Prospective cohort study. SETTING: Fifteen private and academic fertility centers (14 in the United States and 1 in Canada). PATIENT(S): Women aged 21-45 years planning controlled ovarian stimulation for in vitro fertilization. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved, categorized as POR and normal-to-high ovarian response (non-POR). The correlation of AMH level and antral follicle count. RESULT(S): Data were available for 472 participants who completed the study (74 with POR and 398 non-POR). The mean AMH serum level among those with POR was 0.99 ng/mL (median 0.76 ng/mL) compared with 2.83 ng/mL (median 2.36 ng/mL) among the normal-to-high responders. For confirmation of the 0.93 ng/mL AMH level cutoff as a predictor of POR, a receiver operating characteristic analysis gave an area under the curve of 0.852, with corresponding sensitivity and specificity of 63.5% and 89.2%, respectively. The associated positive predictive value was 52.2% and the negative predictive value was 92.9%. The AMH plasma values demonstrated a strong correlation with AMH serum values with an r value = 0.9980. The previously established AMH cutoff of 1.77 ng/mL for antral follicle count >15 resulted in a sensitivity of 83.8% (95% confidence interval [CI] 77.7-88.5) and a specificity of 59.9% (95% CI 54.2-65.4). CONCLUSION(S): This study validated the previously established AMH cut-point for the prediction of POR. Because this cut-point may vary depending on the assay used, the specific AMH assay should be reported in the literature whenever possible.
引用
- Baker VL, Glassner MJ, Doody K, et al. Validation study of the Access antimüllerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2021. PMID: 33812650. doi:10.1016/j.fertnstert.2021.01.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。